Sphingolipid imbalances inflame the bowel

Sphingolipid imbalances inflame the bowel

Bibliographic Details
Main Author:	Kirsty M. Hooper
Format:	Article
Language:	English
Published:	The Company of Biologists 2023-09-01
Series:	Disease Models & Mechanisms
Online Access:	http://dmm.biologists.org/content/16/9/dmm050472

Similar Items

Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer
by: Keila S. Espinoza, et al.
Published: (2024-02-01)

Dynamic, Transient, and Robust Increase in the Innervation of the Inflamed Mucosa in Inflammatory Bowel Diseases
by: Miguel Gonzalez Acera, et al.
Published: (2021-08-01)

The Microbiota Profile in Inflamed and Non-Inflamed Ileal Pouch–Anal Anastomosis
by: Sabrina Just Kousgaard, et al.
Published: (2020-10-01)

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children
by: Aleksandra Filimoniuk, et al.
Published: (2020-07-01)

Inflaming the Brain with Iron
by: Pamela J. Urrutia, et al.
Published: (2021-01-01)

Beyond an Inflamed Ear
by: Cristina Ponte, et al.
Published: (2014-12-01)

Sphingolipid biology /
by: Hirabayashi, Yoshio, et al.
Published: (2006)

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
by: Brianna M. Quinville, et al.
Published: (2021-05-01)

Decreased potassium channel IK1 and its regulator neurotrophin-3 (NT-3) in inflamed human bowel.
by: Arnold, S, et al.
Published: (2003)

Sphingolipids and Mitochondrial Dynamic
by: Lais Brigliadori Fugio, et al.
Published: (2020-03-01)

Sphingolipids in neurodegenerative diseases
by: Xueyang Pan, et al.
Published: (2023-02-01)

Sphingolipids in ischemic stroke
by: Anastasia A. Rogozhina
Published: (2022-01-01)

Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
by: Ruben Y. Gabriëls, et al.
Published: (2022-07-01)

Identification of Diagnostic Biomarkers by Bioinformatics Analysis in the Inflamed and Non-inflamed Intestinal Mucosa of Patients With Crohn’s Disease
by: Mohsen Sheykhhasan, et al.
Published: (2021-08-01)

Editorial: Sphingolipid metabolism and cancer
by: Margarita M. Ivanova, et al.
Published: (2022-11-01)

Relapsing Polychondritis: Inflamed Joints and Ears
by: Meltem Alkan Melikoğlu, et al.
Published: (2015-03-01)

The Implication of Sphingolipids in Viral Infections
by: Sanya Thomas, et al.
Published: (2023-12-01)

Dysregulation of sphingolipid metabolism in pain
by: Jianfeng Wang, et al.
Published: (2024-03-01)

Targeting the Sphingolipid Rheostat in Gliomas
by: Faris Zaibaq, et al.
Published: (2022-08-01)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
by: Mateusz Matwiejuk, et al.
Published: (2022-11-01)

Sphingolipid Mediators of Myocardial Pathology
by: Anna Kovilakath, et al.
Published: (2020-01-01)

The Role of Sphingolipids in Cancer Immunotherapy
by: Paola Giussani, et al.
Published: (2021-06-01)

Neurodegenerative Disorders: Spotlight on Sphingolipids
by: Frida Mandik, et al.
Published: (2021-11-01)

Sphingolipids in thyroid eye disease
by: Anne Gulbins, et al.
Published: (2023-04-01)

Circulating sphingolipids in heart failure
by: Anna Kovilakath, et al.
Published: (2023-05-01)

Regulation of Necroptosis by Phospholipids and Sphingolipids
by: Xuewei Zhang, et al.
Published: (2020-03-01)

Sphingolipids of plant pathogenic fungi
by: Lucia Gharwalová, et al.
Published: (2021-06-01)

Exploring Sphingolipid Implications in Neurodegeneration
by: Alice V. Alessenko, et al.
Published: (2020-05-01)

The Enigma of Sphingolipids in Health and Disease
by: Burkhard Kleuser
Published: (2018-10-01)

Towards a multidimensional model of inflamed depression
by: Maria Teresa Wijaya, et al.
Published: (2022-12-01)

Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration
by: Maria Ayub, et al.
Published: (2021-07-01)

Sphingolipids in Atherosclerosis: Chimeras in Structure and Function
by: Lisa Peters, et al.
Published: (2022-10-01)

Extensive Histopathological Characterization of Inflamed Bowel in the Dextran Sulfate Sodium Mouse Model with Emphasis on Clinically Relevant Biomarkers and Targets for Drug Development
by: Rita Bonfiglio, et al.
Published: (2021-02-01)

Selective recruitment of lymphocyte subsets to the inflamed appendix.
by: Soo, K, et al.
Published: (1995)

Biochemical Mapping of the Inflamed Human Dental Pulp
by: Konstantina Kritikou, et al.
Published: (2021-11-01)

Heme Peroxidases at Unperturbed and Inflamed Mucous Surfaces
by: Jürgen Arnhold
Published: (2021-11-01)

Inverse and Concordant Mucosal Pathway Gene Expressions in Inflamed and Non-Inflamed Ulcerative Colitis Patients: Potential Relevance to Aetiology and Pathogenesis
by: Jan Söderman, et al.
Published: (2022-06-01)

The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”
by: Melissa Bersanelli, et al.
Published: (2021-07-01)

Editorial: Sphingolipids in infections, diseases, and disorders
by: Farha Naz, et al.
Published: (2024-03-01)

Implications of Sphingolipid Metabolites in Kidney Diseases
by: Shamroop kumar Mallela, et al.
Published: (2022-04-01)